http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbebc124b5a48259041649e9bab4753c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Flinn |
| name | Ian W. Flinn Ian W Flinn |
| given-name | Ian W. Ian W |
| organization-name | Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN. From the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Dana-Farber Cancer Institute, Boston, MA; School of Medicine, Ohio State University, Columbus; Cleveland Clinic Foundation, Cleveland, OH; Mayo Clinic, Rochester, MN; University of Rochester Cancer Center, Rochester, NY; Our Lady of Mercy Medical Center, Bronx, NY; Fred Hutchinson Cancer Research Center, Seattle, WA; University of Chicago; Cancer and Leukemia Group B, Feinberg School of Medicine, Northwestern University,... Sarah Cannon Research Institute, Tennessee Oncology, Nashville, Tennessee. Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; From Johns Hopkins Oncology Center, Baltimore, MD, and Walter Reed Army Medical Center, Washington, DC. Ronald Levy, Andrew J. Gentles, Chih Long Liu, Robert Tibshirani, and Ash A. Alizadeh, Stanford University Medical Center, Palo Alto; Christos E. Emmanouilides and John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles; Lori A. Kunkel, Diane E. Ingolia, and Dan W. Denney Jr, Genitope, Fremont, CA; Kristen N. Ganjoo and Michael J. Robertson, Indiana University Medical Center, Indianapolis, IN; John P. Leonard, Weill Medical College of Cornell University, New York, NY; Julie M.... Blood Cancer Research Program, Sarah Cannon Research Institute, Nashville, TN, USA The Sarah Cannon Research Institute Nashville TN USA Sarah Cannon Research Institute, Nashville, Tennessee, USA; Tennessee Oncology, PLLC, Nashville, Tennesse, USA Sarah Cannon Research Institute Tennessee Sarah Cannon Research Institute Nashville Tennessee; Tennessee Oncology Nashville Tennessee From the Division of Hematology-Oncology, The Ohio State University, Columbus; Division of Hematologic Malignancies, Johns Hopkins Oncology Center, Baltimore, MD; and Burnham Institute, Cancer Research Center, La Jolla, CA. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bunting-Blaustein Cancer Research Building, 1650 Orleans Street/Room 388, Baltimore, MD 21231-1000, USA. Sarah Cannon Research Institute Nashville TN USA Sarah Cannon Research Institute Tennessee Oncology Nashville TN Center for Blood Cancer Sarah Cannon Research Institute/Tennessee Oncology Nashville Tennessee SARAH CANNON RESEARCH INSTITUTE From the Johns Hopkins Oncology Center, Baltimore, MD. Sarah Cannon Research Institute, Nashville, TN Sarah Cannon Research Institute, Nashville, TN;; Tennessee Oncology, Nashville, TN; Hematologic Malignancies Research Program, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA Sarah Cannon Research Institute, Nashville, TN; 3Sarah Cannon Research Institute, Nashville, Tennessee. Sarah Cannon Research Institute and Tennessee Oncology PLLC Nashville TN USA Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN, USA From the Department of Pathology, the Ohio State University, Columbus, OH; the Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD; the Division of Hematology-Oncology, the Ohio State University, Columbus, OH; and Vysis Incorporated, Downers Grove, IL. From the Division of Hematology-Oncology, Walter Reed Army Medical Center, Washington, DC; the Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD; and the Division of Hematologic Malignancies, Johns Hopkins Oncology Center, Baltimore, MD. Sarah Cannon Research Institute, Nashville, TN, USA From the Oncology Center, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Pathology, University of Birmingham Medical School, United Kingdom; Comprehensive Cancer Center, The Ohio State University, Columbus, OH. Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; and From the Division of Hematology-Oncology, Department of Medicine and the Department of Clinical Investigation, Walter Reed Army Medical Center, Washington, DC; Division of Hematologic Malignancies, Johns Hopkins Oncology Center, Baltimore; Department of Critical Care Medicine, Uniformed Services University of Health Sciences, Bethesda, MD; Department of Medicine, The Ohio State University, Columbus, OH; IDEC Pharmaceuticals Inc, San Diego; and Genentech Pharmaceuticals, Inc, San Francisco, CA. 4Hematology/Oncology, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee. 5Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, Maryland 1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN From Memorial Sloan Kettering Cancer Center (A.R.M.), and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center (N.L.), New York, the Donald and Barbara Zucker School of Medicine, Northwell–Hofstra, Uniondale (J.M.R.), Northwell Health Cancer Institute at Lake Success, North New Hyde Park (J.M.R.), and the Lymphoma Section, Department of Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo (F.H.-I.) — all in New York; the Ohio State University Comprehensive Cancer... Tennessee Oncology/Sarah Cannon Research Institute, Nashville, TN; Sarah Cannon Cancer Institute, Nashville, TN; Sarah Cannon Research Institute, Nashville, TN; Tennessee Oncology, Nashville, TN From the Hematology-Oncology Service, Madigan Army Medical Center, Tacoma, WA; Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD; Burnham Institute, Cancer Research Center, La Jolla, CA; and Division of Hematology-Oncology, The Ohio State University, Columbus, OH. Division of Hematologic Malignancies, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Md. Sarah Cannon Research Institute, Nashville, TN, USA; From the Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin NT, Hong Kong SAR, China; Cancer Epigenetics/Tumor Virology Laboratory, Johns Hopkins Singapore, Singapore; Epigenetic Gene Regulation and Cancer Section, National Cancer Institute, National Institutes of Health, Bethesda; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Department of Medicine, University of California San Francisco-Mt. Zion Hospital, San Francisco, CA Sarah Cannon Research Institute, Nashville, Tennessee, USA; Tennessee Oncology, PLLC, Nashville, Tennessee, USA Ruben Niesvizky, Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY; Ian W. Flinn, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Robert Rifkin, US Oncology Research/McKesson Specialty Health, The Woodlands, TX; Nashat Gabrail, Gabrail Cancer Center, Canton, OH; Veena Charu, Pacific Cancer Medical Center, Anaheim, CA; Billy Clowney, Santee Hematology/Oncology, Sumter, SC; James Essell, Sarah Cannon Research Institute and Oncology Hematology Care,... Sarah Cannon Research Institute-Tennessee Oncology, Nashville, TN; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN; From the Oncology Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231. Sarah Cannon Research Institute Nashville Tennessee USA Oncology, Sarah Cannon Research Institute, Nashville, TN; 2Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland;; 5Sarah Cannon Research Institute, Nashville, Tennessee Tennesee Oncology, Nashville, TN, USA; Sarah Cannon Blood Cancer Network, Nashville, TN, USA 3Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN From the Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; Southwest Oncology Group; Division of Hematology-Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH; Department of Cytogenetics, Mayo Clinic; Mayo Clinic College of Medicine, Rochester, MN; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; Burnham Institute for Medical Research, La Jolla, CA; Department of Oncology, Johns Hopkins University, Baltimore,... From the University of Texas M.D. Anderson Cancer Center, Houston (M.W.), and Texas Oncology, Dallas (H.H.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (J.M.); John Theurer Cancer Center, Hackensack, NJ (A.G.); Moffitt Cancer Center, Tampa (F.L.L.), and the University of Miami, Miami (A.B.) — both in Florida; Dana–Farber Cancer Institute, Boston (C.A.J.); Cleveland Clinic Foundation, Cleveland (B.T.H.), and the Ohio State University Comprehensive Cancer Center, Columbus (S.J.); David Geffen School... From the Division of Hematology-Oncology and the Department of Biostatistics, Ohio State University, Columbus; the Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD; and BioServe Biotechnologies, Laurel, MD. John P. Leonard, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY; Kathryn S. Kolibaba, Compass Oncology, Vancouver, WA; Kathryn S. Kolibaba and Nicholas J. DiBella, US Oncology Research, The Woodlands; Robert Collins, University of Texas Southwestern Medical Center, Dallas, TX; James A. Reeves, Florida Cancer Specialists, Fort Myers; Julio Hajdenberg, University of Florida Health Cancer Center at Orlando Health, Orlando, FL; Anil Tulpule, Keck Medicine of University of Southern... Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN Sarah Cannon Research Institute, Nashville, Tennessee. From the Department of Medicine, Division of Hematology-Oncology, and the Department of Pharmacy, Division of Medicinal Chemistry, The Ohio State University, Columbus; the Department of Oncology, Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD; and BioServe Biotechnologies, Laurel, MD. Sarah Cannon Research Institute/Tennessee Oncology Nashville Tennessee Sarah Cannon Research Institute/Tennessee Oncology PLLC Nashville TN USA From the Mayo Clinic, Rochester, MN; Johns Hopkins Oncology Center, Baltimore, MD; Northwestern University/Robert H. Lurie Cancer Center, Chicago, IL; University of California, Los Angeles, and IDEC Pharmaceuticals Corporation, San Diego, CA; Roswell Park Cancer Institute, Buffalo, NY; University of Alabama, Birmingham, AL; and Indiana Cancer Pavilion, Indianapolis, IN. From the Division of Hematology-Oncology, Walter Reed Army Medical Center, Washington, DC; the Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD; the Division of Hematologic Malignancies, Johns Hopkins Oncology Center, Baltimore, MD; Biotechnologies, Ltd, Laurel, MD; the Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN; and the Developmental Therapeutics Program, National Cancer Institute, Bethesda, MD. Hematologic Malignancies Research Program Sarah Cannon Research Institute Nashville TN USA |
Incoming Links
Total number of triples: 229.